Arndt-René Kelter

Title: Arndt-René Kelter: Innovator in Pharmaceutical Compositions

Introduction

Arndt-René Kelter is a notable inventor based in Alfter, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thienopyrimidine compounds. His research focuses on the development of novel pharmaceutical compositions that have the potential to treat various diseases.

Latest Patents

Kelter holds a patent for "Thienopyrimidines having Mnk1/Mnk2 inhibiting activity for pharmaceutical compositions." This invention relates to new pharmaceutical compositions that comprise thienopyrimidine compounds. The patent outlines the use of these compounds for the production of pharmaceutical compositions aimed at the prophylaxis and treatment of diseases influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2.

Career Highlights

Arndt-René Kelter is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has allowed him to contribute to the advancement of medical science through innovative drug development.

Collaborations

Kelter has collaborated with notable colleagues, including Babette Aicher and Thomas Stephen Coulter. These collaborations have further enhanced the research and development efforts in the pharmaceutical domain.

Conclusion

Arndt-René Kelter's contributions to pharmaceutical innovations, particularly through his patent on thienopyrimidine compounds, highlight his role as a significant inventor in the field. His work continues to influence the development of new treatments for various diseases.